Ixazomib Approved To Treat Multiple Myeloma


Ixazomib (Ninlaro, Takeda) in combination with lenalidomide (Revlimid, Celgene) and dexamethasone is now approved to treat people with multiple myeloma who have received at least one prior therapy. The drug, according to the FDA report, helped patients to live longer without their disease worsening. Ixazomib, the first oral proteasome inhibitor, blocks enzymes from multiple myeloma [...]